(Hypertension. 2001;38:602.)
© 2001 American Heart Association, Inc.
Cardiovascular Biology |
Department of Medicine and Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina (J.C., A.A.J.), Charleston; and Deparmento de Ciencias Fisiológicas, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile (V.V.), Chile.
Correspondence to Ayad A Jaffa, PhD, Associate Professor of Medicine, Endocrinology-DiabetesMedical Genetics, Medical University of South Carolina, 114 Doughty St, Charleston, SC 29425. E-mail jaffaa{at}musc.edu
Abstract
Abstract Vascular smooth muscle cell (VSMC) proliferation is a prominent feature of the atherosclerotic process that occurs after endothelial injury. Although a vascular wall kallikrein-kinin system has been described, its contribution to vascular disease remains undefined. Because the B1-kinin receptor subtype (B1KR) is induced in VSMCs only in response to injury, we hypothesize that this receptor may be mediating critical events in the progression of vascular disease. In the present study, we provide evidence that des-Arg9-bradykinin (dABK) (10-8 M), acting through B1KR, stimulates the phosphorylation of mitogen-activated protein kinase (MAPK) (p42mapk and p44mapk). Activation of MAPK by dABK is mediated via a cholera toxinsensitive pathway and appears to involve protein kinase C, Src kinase, and MAPK kinase. These findings demonstrate that the activation of B1KR in VSMCs leads to the generation of second messengers that converge to activate MAPK and provide a rationale to investigate the mitogenic actions of dABK in vascular injury.
Key Words: receptors, kinin, B1 protein kinases muscle, smooth, vascular
This article has been cited by other articles:
![]() |
G. S. Ceravolo, L. Fernandes, C. D. Munhoz, D. C. Fernandes, R. C.A. Tostes, F. R.M. Laurindo, C. Scavone, Z. B. Fortes, and M. H. C. Carvalho Angiotensin II Chronic Infusion Induces B1 Receptor Expression in Aorta of Rats Hypertension, October 1, 2007; 50(4): 756 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ignjatovic, S. Stanisavljevic, V. Brovkovych, R. A. Skidgel, and E. G. Erdos Kinin B1 Receptors Stimulate Nitric Oxide Production in Endothelial Cells: Signaling Pathways Activated by Angiotensin I-Converting Enzyme Inhibitors and Peptide Ligands Mol. Pharmacol., November 1, 2004; 66(5): 1310 - 1316. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |